相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical uses of anti-Mullerian hormone assays: pitfalls and promises
Isabelle Streuli et al.
FERTILITY AND STERILITY (2009)
Serum inhibin B and anti-Mullerian hormone are not superior to follicle-stimulating hormone as predictors of the presence of sperm in testicular fine-needle aspiration in men with azoospermia
Dimitrios G. Goulis et al.
FERTILITY AND STERILITY (2009)
Anti-Mullerian hormone in men with normal and reduced sperm concentration and men with maldescended testes
Frank Tuettelmann et al.
FERTILITY AND STERILITY (2009)
The effect of weight loss on anti-Mullerian hormone levels in overweight and obese women with polycystic ovary syndrome and reproductive impairment
R. L. Thomson et al.
HUMAN REPRODUCTION (2009)
Anti-Mullerian hormone concentrations in androgen-suppressed women with polycystic ovary syndrome
S. M. Carlsen et al.
HUMAN REPRODUCTION (2009)
Anti-Mullerian hormone (AMH): what do we still need to know?
A. La Marca et al.
HUMAN REPRODUCTION (2009)
Mild ovarian stimulation for IVF
M. F. G. Verberg et al.
HUMAN REPRODUCTION UPDATE (2009)
Poor responder protocols for in-vitro fertilization: options and results
Dimitris Loutradis et al.
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2008)
The role of mullerian inhibiting substance in female reproduction
Gary S. Nakhuda
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2008)
Anti-Mullerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients
Eman A. Elgindy et al.
FERTILITY AND STERILITY (2008)
Significance of inhibin B and anti-Mullerian hormone in seminal plasma: a preliminary study
Emma Duvilla et al.
FERTILITY AND STERILITY (2008)
Statistically significant changes of antimuillerian hormone and inhibin levels during the physiologic menstrual cycle in reproductive age women
Dorothea M. Wunder et al.
FERTILITY AND STERILITY (2008)
Serum antimullerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids
Isabelle Streuli et al.
FERTILITY AND STERILITY (2008)
The endocrine and follicular growth dynamics throughout the menstrual cycle in women with consistently or variably elevated early follicular phase FSH compared with controls
C. H. de Koning et al.
HUMAN REPRODUCTION (2008)
Relevance of anti-Mullerian hormone measurement in a routine IVF program
C. Gnoth et al.
HUMAN REPRODUCTION (2008)
GnRH agonist for triggering final oocyte maturation in patients at risk of ovarian hyperstimulation syndrome: still a controversy?
S. Kol et al.
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS (2008)
Anti-Mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition
MaryFran R. Sowers et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Relationship of serum antimullerian hormone concentration to age at menopause
J. van Disseldorp et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Analysis of serum levels of anti-Mullerian hormone, inhibin B, insulin-like growth factor-I, insulin-like growth factor binding protein-3, and follicle-stimulating hormone with respect to age and menopausal status
Sun Young Shin et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2008)
Serum anti-Mullerian hormone and inhibin B levels at ovulation triggering day can predict the number of immature oocytes retrieved in in vitro fertilization cycles
Byung Chul Jee et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2008)
A proposed classification system for menstrual cycles in the menopause transition based on changes in serum hormone profiles
David M. Robertson et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2008)
Body size affects measures of ovarian reserve in late reproductive age women
H. Irene Su et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2008)
Anti-Mullerian hormone and ovarian dysfunction
Frank J. Broekmans et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2008)
Serum anti-Mullerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles
Tsung-Hsien Leeh et al.
HUMAN REPRODUCTION (2008)
Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation
B. C. J. M. Fauser et al.
HUMAN REPRODUCTION UPDATE (2008)
Serum anti-muillerian hormone levels and follicular cohort characteristics after vituitarv supmession in the late luteal phase with oral contraceptive pills
E. Arbo et al.
HUMAN REPRODUCTION (2007)
Anti-Mullerian hormone levels during hormonal contraception in women with polycystic ovary syndrome
Asli Somunkiran et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2007)
The use of anti-mullerian hormone in predicting menstrual response after weight loss in overweight women with polycystic ovary syndrome
Lisa J. Moran et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Mullerian Inhibiting Substance is an ovarian growth factor of emerging clinical significance
David B. Seifer et al.
FERTILITY AND STERILITY (2007)
Actions of anti-Mullerian hormone on the ovarian transcriptome to inhibit primordial to primary follicle transition
Eric Nilsson et al.
REPRODUCTION (2007)
Stable serum levels of anti-Mullerian hormone during the menstrual cycle: a prospective study in normo-ovulatory women
S. Tsepelidis et al.
HUMAN REPRODUCTION (2007)
Anti-Mullerian hormone and anti-Mullerian hormone type II receptor polymorphisms are associated with follicular phase estradiol levels in normo-ovulatory women
Marlies E. Kevenaar et al.
HUMAN REPRODUCTION (2007)
Serum anti-mullerian hormone concentrations are not altered by acute administration of follicle stimulating hormone in polycystic ovary syndrome and normal women
Deborah S. Wachs et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Anti-Mullerian hormone concentrations in the follicular fluid of the preovulatory follicle are predictive of the implantation potential of the ensuing embryo obtained by in vitro fertilization
Renato Fanchin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial
Esther M. E. W. Heijnen et al.
LANCET (2007)
Anti-Mullerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology
A. La Marca et al.
HUMAN REPRODUCTION (2007)
Evaluation of the utility of multiple endocrine and ultrasound measures of ovarian reserve in the prediction of cycle cancellation in a high-risk IVF population
M. McIlveen et al.
HUMAN REPRODUCTION (2007)
The probability of successful IVF outcome after poor ovarian response
Pia Saldeen et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2007)
Measurement of serum Anti-Mullerian hormone by Beckman Coulter ELISA and DSL ELISA: Comparison and relevance in Assisted Reproduction Technology (ART)
Thomas Freour et al.
CLINICA CHIMICA ACTA (2007)
Measurement of anti-mullerian hormone by Beckman Coulter ELISA and DSL ELISA in assisted reproduction: differences between serum and follicular fluid
Nick A. Bersinger et al.
CLINICA CHIMICA ACTA (2007)
Granulosa cell production of anti-Mullerian hormone is increased in polycystic ovaries
Laura Pellatt et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Mullerian inhibiting substance and disrupted folliculogenesis in polycystic ovary syndrome
Jeff G. Wang et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2007)
Serum anti-Mullerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles - implications for individualization of therapy
Scott M. Nelson et al.
HUMAN REPRODUCTION (2007)
Association of anti-mullerian hormone levels with obesity in late reproductive-age women
Ellen W. Freeman et al.
FERTILITY AND STERILITY (2007)
Seminal plasma anti-Mullerian hormone level correlates with semen parameters but does not predict success of testicular sperm extraction (TESE)
Taymour Mostafa et al.
ASIAN JOURNAL OF ANDROLOGY (2007)
Serum anti-Mullerian hormone throughout the human menstrual cycle
A. La Marca et al.
HUMAN REPRODUCTION (2006)
A systematic review of tests predicting ovarian reserve and IVF outcome
F. J. Broekmans et al.
HUMAN REPRODUCTION UPDATE (2006)
Time course of the serum gonadotropin surge, inhibins, and anti-Mullerian hormone in normal newborn males during the first month of life
Ignacio Bergada et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Anti-Mullerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation
Wouter J. K. Hehenkamp et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Estradiol and regulation of anti-Mullerian hormone, inhibin-A, and inhibin-B secretion: Analysis of small antral and preovulatory human follicles' fluid
Claus Yding Andersen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Anti-Mullerian hormone inhibits initiation of growth of human primordial ovarian follicles in vitro
I. B. Carlsson et al.
HUMAN REPRODUCTION (2006)
Basal level of anti-Mullerian hormone is associated with oocyte quality in stimulated cycles
T. Ebner et al.
HUMAN REPRODUCTION (2006)
Dynamics of FSH-induced follicular growth in subfertile women: relationship with age, insulin resistance, oocyte yield and anti-Mullerian hormone
R Fleming et al.
HUMAN REPRODUCTION (2006)
Serum anti-Mullerian hormone levels do not predict the efficiency of testicular sperm retrieval in men with non-obstructive azoospermia
Mete Isikoglu et al.
GYNECOLOGICAL ENDOCRINOLOGY (2006)
Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer
Nicola Doldi et al.
GYNECOLOGICAL ENDOCRINOLOGY (2006)
The science behind 25 years of ovarian stimulation for in vitro fertilization
NS Macklon et al.
ENDOCRINE REVIEWS (2006)
Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome
P Pigny et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis
G Griesinger et al.
HUMAN REPRODUCTION UPDATE (2006)
Early follicular antimullerian hormone as an indicator OT ovarian reserve
C Fiçicioglu et al.
FERTILITY AND STERILITY (2006)
Mullerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology
T Silberstein et al.
HUMAN REPRODUCTION (2006)
Anti-Mullerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool?
A. La Marca et al.
CLINICAL ENDOCRINOLOGY (2006)
Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome
T Eldar-Geva et al.
HUMAN REPRODUCTION (2005)
Development of a sensitive enzyme immunoassay for anti-Mullerian hormone and the evaluation of potential clinical applications in males and females
A Al-Qahtani et al.
CLINICAL ENDOCRINOLOGY (2005)
The relationship between obesity and race on inhibin B during the menopause transition
CR Gracia et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2005)
Polycystic ovaries and ovarian hyperstimulation syndrome: a systematic review
I Tummon et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2005)
Serum anti-Mullerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome
T Piltonen et al.
HUMAN REPRODUCTION (2005)
Per-follicle measurements indicate that anti-mullerian hormone secretion is modulated by the extent of follicular development and luteinization and may reflect qualitatively the ovarian follicular status
R Fanchin et al.
FERTILITY AND STERILITY (2005)
Anti-Mullerian hormone concentrations in maternal serum during pregnancy
A La Marca et al.
HUMAN REPRODUCTION (2005)
Anti-Mullerian hormone and folliculogenesis
JA Visser et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2005)
Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study
IAJ van Rooij et al.
FERTILITY AND STERILITY (2005)
Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist-gonadotropin treatment
J Peñarrubia et al.
HUMAN REPRODUCTION (2005)
High reproducibility of serum anti-Mullerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status
R Fanchin et al.
HUMAN REPRODUCTION (2005)
Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial
ER Klinkert et al.
HUMAN REPRODUCTION (2005)
Anti-mullerian hormone as a marker of ovarian reserve
KP Tremellen et al.
AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY (2005)
Antral follicle count in the prediction of poor ovarian response and pregnancy after in vitro fertilization: a meta-analysis and comparison with basal folliclestimulating hormone level
DJ Hendriks et al.
FERTILITY AND STERILITY (2005)
A poor response in the first in vitro fertilization cycle is not necessarily related to a poor prognosis in subsequent cycles
ER Klinkert et al.
FERTILITY AND STERILITY (2004)
Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment
C Weenen et al.
MOLECULAR HUMAN REPRODUCTION (2004)
Changes in anti-Mullerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility
AGMGJ Mulders et al.
HUMAN REPRODUCTION (2004)
Anti-Mullerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation
A La Marca et al.
HUMAN REPRODUCTION (2004)
Defining poor ovarian response during IVF cycles, in women aged <40 years, and its relationship with treatment outcome
C Kailasam et al.
HUMAN REPRODUCTION (2004)
Anti-Mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age
JSE Laven et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Serum antimullerian hormone/mullerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol
A Hazout et al.
FERTILITY AND STERILITY (2004)
Impact of overweight and underweight on assisted reproduction treatment
P Fedorcsák et al.
HUMAN REPRODUCTION (2004)
AMH signaling: from receptor to target gene
JA Visser
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2003)
Anti-Mullerian hormone levels in serum from human foetuses and children:: pattern and clinical interest
J Guibourdenche et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2003)
Components of the anti-Mullerian hormone signaling pathway in gonads
N di Clemente et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2003)
Intravenous albumin does not prevent moderate-severe ovarian hyperstimulation syndrome in high-risk IVF patients:: a randomized controlled study
J Bellver et al.
HUMAN REPRODUCTION (2003)
Formation and early development of follicles in the polycystic ovary
LJ Webber et al.
LANCET (2003)
Serum anti-Mullerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3
R Fanchin et al.
HUMAN REPRODUCTION (2003)
Serum anti-Mullerian hormone dynamics during controlled ovarian hyperstimulation
R Fanchin et al.
HUMAN REPRODUCTION (2003)
A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol
FP Hohmann et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Elevated serum level of anti-Mullerian hormone in patients with polycystic ovary syndrome: Relationship to the ovarian follicle excess and to the follicular arrest
P Pigny et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
A prospective randomized clinical trial comparing an individual dose of recombinant FSH based on predictive factors versus a 'standard' dose of 150 IU/day in 'standard' patients undergoing IVF/ICSI treatment
B Popovic-Todorovic et al.
HUMAN REPRODUCTION (2003)
Clinical management of low ovarian response to stimulation for IVF: a systematic review
BC Tarlatzis et al.
HUMAN REPRODUCTION UPDATE (2003)
Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve
IAJ van Rooij et al.
HUMAN REPRODUCTION (2002)
Young age does not protect against the adverse effects of reduced ovarian reserve - an eight year study
T El-Toukhy et al.
HUMAN REPRODUCTION (2002)
The use of GnRH antagonists in ovarian stimulation
F Olivennes et al.
HUMAN REPRODUCTION UPDATE (2002)
The significance of anti-Mullerian hormone concentration in seminal plasma for spermatogenesis
M Fujisawa et al.
HUMAN REPRODUCTION (2002)
Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve
LFJMM Bancsi et al.
FERTILITY AND STERILITY (2002)
Relationship between serum mullerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women
CL Cook et al.
FERTILITY AND STERILITY (2002)
Physical activity, body mass index, and ovulatory disorder infertility
JW Rich-Edwards et al.
EPIDEMIOLOGY (2002)
Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles
DB Seifer et al.
FERTILITY AND STERILITY (2002)
Anti-Mullerian hormone attenuates the effects of FSH on follicle development in the mouse ovary
ALL Durlinger et al.
ENDOCRINOLOGY (2001)
Anti-Mullerian hormone and its receptors
N Josso et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2001)
Low-dose exogenous FSH initiated during the early, mid or late follicular phase can induce multiple dominant follicle development
FP Hohmann et al.
HUMAN REPRODUCTION (2001)
分享论文
